Results 91 to 100 of about 1,163 (152)

Improving Polypharmacy and Medication Review in the Elderly [PDF]

open access: yes, 2023
Polypharmacy in elderly patients increases risk of adverse drug events, which can cause health and functional impairment, necessitating considerate medication review. Many patients do not remember the names or doses of their medications when asked in the
Maness, Caleb P.
core   +1 more source

Approches soignantes lors de troubles du sommeil associés aux troubles neurocognitifs chez l'aîné institutionnalisé: revue de la littérature [PDF]

open access: yes, 2017
La prévalence des troubles du sommeil chez l’aîné ne cesse d’augmenter. Ces troubles se péjorent avec l’institutionnalisation et risquent de s’aggraver lorsqu’ils sont associés à des troubles neurocognitifs.
Fardel, Manon, Faure-Arnaud, Dominique
core  

Drug deprescription-withdrawal risk, prevention, and treatment [PDF]

open access: yes, 2020
In most cases, a sudden interruption of most medications has no major consequences. There are well-recognized therapies that, when withheld, can either lead to the reappearance of the symptoms they were controlling or to signs or symptoms of withdrawal ...
Aisenberg, Gabriel M, Bangert, Madison K
core   +1 more source

Visualisation of limb movements by accelerometers in sedated patients [PDF]

open access: yes, 2021
Bakgrunn Vurdering av nevrologisk prognose for intensivpasienter er i dag utfordrende. Kliniske undersøkelser og scoringsskjema tas i bruk, der ulike motoriske responser er verdifulle variabler. Sensorer med akselerometer gir oss muligheten til å presist
Harbo Flinstad, Erlend
core  

[Deprescription in old people: It's time to take action].

open access: yesAtencion primaria, 2022
The use of drugs has undeniable benefits to the elderly, but it is not exempt from undesirable effects. Deprescription is the process of systematic medication review with the target of achieving the best risk-benefit ratio based on the best available evidence.
García Pliego, Rosa Ana   +3 more
openaire   +2 more sources

Re-Audit of Safe Deprescribing on Inpatient Psychiatric Wards After Implementation of an Electronic Prescribing Management and Administration (EPMA) System in an NHS Trust

open access: yesBJPsych Open
Aims: The audit aimed to evaluate the effectiveness of transitioning from paper-based patient prescription charts (Kardex) to an electronic prescribing and medication administration system (EPMA) in improving compliance with safe deprescribing practices ...
Udoka Onyechere   +2 more
doaj   +1 more source

Cost-utility analysis of benzodiazepine deprescription in primary care: a cohort study

open access: yesBMC Health Services Research
Background Long-term benzodiazepine (BZD) use is associated with adverse clinical outcomes and increased healthcare utilization. Although deprescription programs aim to reduce these risks, the net economic impact of BZD discontinuation—particularly in ...
Ingrid Ferrer López   +7 more
doaj   +1 more source

Deprescribing: What are the views and factors influencing this concept among patients with chronic diseases in a developed Asian community?

open access: yesProceedings of Singapore Healthcare, 2017
Objective: Public primary healthcare clinics in Singapore manage a large proportion of elderly patients with chronic diseases. Inappropriate prescribing of medications and polypharmacy in the elderly are associated with adverse outcomes.
Wei Ling Ng   +3 more
doaj   +1 more source

Primary carE PPi dEprescRibing (PEPPER) trial: a protocol for determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients

open access: yesBMJ Open
Introduction Current Belgian guidelines state that chronic proton pump inhibitor (PPI) therapy is indicated for oesophagitis grade C and D, Barrett’s oesophagus, Zollinger-Ellison syndrome, or to prevent bleeding ulcers with chronic non-steroidal anti ...
Jan Tack   +4 more
doaj   +1 more source

Reducción gradual de dosis frente a deprescripción abrupta de antipsicóticos en pacientes con demencia: una revisión sistemática [PDF]

open access: yes
Objective: To synthesize the available evidence on antipsychotic gradual dose reduction or abrupt deprescription in the older people population with dementia. Methods: A systematic review of intervention studies.
Martin-Ruiz, Eva   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy